Wanda Cui on measuring ovarian toxicity

Cheryl Reeves, Senior Editor at The Lancet Oncology, is joined by Dr Jinming Li, from the Department of Colorectal Surgery, Fudan University Shanghai Cancer Centre, Shanghai, China to discuss his international, multicohort, observational study on patterns in genomic mutations amo ... Show More

Jamie Prowse, Senior Editor at The Lancet Oncology, is joined by Professor Abdalla Awidi (Founder and Director of Stem Cell Therapy Center, University of Jordan, Amman, Jordan) to discuss The Lancet Oncology's Cancer control in the Middle East Series. The Series comprises five pa ... Show More

Katherine Gourd, Acting Deputy Editor at The Lancet Oncology, and Vania Wisdom, Senior Executive Editor at The Lancet and the journal's Oncology Ambassador, join Leon Terner to share some of their experiences, impressions and highlights from this year's American Society of Clinic ... Show More

Dr Dana M Chase from the David Geffen School of Medicine at UCLA in Los Angeles, California, discusses select 2023 data sets on the management of ovarian, endometrial and cervical cancers. 

Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More

Today I am speaking with Dr. Leigh Erin Connealy, MD. Dr. Connealy is absolutely amazing, and I was so interested to have her on the podcast because of her incredible experience and philosophy on cancer prevention. We discuss cancer rates, what she recommends for preventing cance ... Show More

Our guest is Dr. Kyle Richards, a urologic oncologist and Associate Professor in the Department of Urology at the University of Wisconsin. He talks with us about the basics around non-muscle invasive bladder cancer. Learn about common symptoms, diagnosis and treatment options to ... Show More

March is colon cancer awareness month so in today's episode, I discuss oncologic treatment options for colorectal cancer with Dr. Hardeep Phull. Dr. Phull is Medical Director of Oncology at Palomar Health and Clinical Instructor at the University of California San Diego. He ... Show More

This week’s episode  is part 2 of 2024 updates focusing on treatment options for localized breast cancer. We will discuss important details on radiation, as well as therapies based on ER/PR/her2 receptor status. We are honored to have Dr. Eleonora Teplinsky, a board-certified med ... Show More

This week, we incorporate medical oncology back into our discussion with our Radiation Oncologist, Dr. Sanford, and our Surgical Oncologist, Dr. Bailey. We discuss how we approach the management of localized rectal cancer. Note that we will be heavily building off our discussions ... Show More

Before immunotherapy, targeted chemotherapy (ADCs) and precision oncology, there was endocrine therapy, the forefather (or mother) of effective treatment to reduce breast cancer recurrence as well as delay disease progression. This episode dives into a past of phenomenal improvem ... Show More

This week, we are joined by Dr. Nina Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology Service, UT Southwestern Medical Center in Dallas, Texas, for a discussion about the role of radiation in colorectal cancer, with an emphasis on the role of radiatio ... Show More